Novavax, Inc. (NVAX)
9.235
-0.12
(-1.34%)
USD |
NASDAQ |
May 07, 16:00
9.28
+0.04
(+0.49%)
After-Hours: 20:00
Novavax EPS Diluted (Quarterly) : -0.0581 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| Moderna, Inc. | -3.40 |
| Johnson & Johnson | 2.141 |
| Intellia Therapeutics, Inc. | -0.8263 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.491M |
| Revenue (Quarterly) | 139.51M |
| Total Expenses (Quarterly) | 149.00M |
| Enterprise Value | 1.030B |
| Gross Profit Margin (Quarterly) | 78.00% |
| Profit Margin (Quarterly) | -6.80% |
| Earnings Yield | -6.47% |
| Operating Earnings Yield | 2.41% |
| Normalized Earnings Yield | 0.0834 |